Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows - (Unaudited)

v3.21.1
Consolidated Statements of Cash Flows - (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net (loss) $ (7,086) $ (2,624)
Adjustments to reconcile net (loss) to net cash (used in) operating activities:    
Depreciation and amortization 914 816
Loss on remeasurement of warrant liability 4,950 0
Stock-based compensation expense 2,376 0
Abandoned project costs 88 0
Equity in net loss of unconsolidated joint ventures 21 1,743
Deferred taxes 116 (659)
Changes in operating assets and liabilities:    
Cash held in escrow 7,480 (2,291)
Real estate inventories (35,755) (245)
Due from affiliates (434) (272)
Other assets (4,539) 1,509
Accounts payable 4,583 515
Accrued expenses and other liabilities (11,060) (7,846)
Due to affiliates 0 281
Net cash (used in) operating activities (38,346) (9,073)
Cash flows from investing activities:    
Purchases of property and equipment (157) (460)
Distributions of capital from unconsolidated joint ventures 4,149 0
Payments for business acquisition, net of cash acquired 0 (128,528)
Net cash provided by (used in) investing activities 3,992 (128,988)
Cash flows from financing activities:    
Borrowings from notes and other debts payable 154,017 195,686
Repayments of notes and other debts payable (100,062) (89,246)
Proceeds from merger, net of fees and other costs 64,434 0
Repayment of convertible note (1,500) 0
Contributions from noncontrolling interests 0 150
Deferred offering costs paid (1,612) (1,194)
Debt issuance costs paid (235) (2,252)
Cash (distributed to) parent, net 0 (6,735)
Net cash provided by financing activities 115,042 96,409
Net increase (decrease) in cash, cash equivalents, and restricted cash 80,688 (41,652)
Cash, cash equivalents, and restricted cash at beginning of period 110,048 156,378
Cash, cash equivalents, and restricted cash at end of period $ 190,736 $ 114,726